Cargando…
N-cadherin expression in malignant germ cell tumours of the testis
BACKGROUND: Testicular germ cell tumours (TGCTs) are the most common malignancy in young men aged 18–35 years. They are clinically and histologically subdivided into seminomas and non-seminomas. Cadherins are calcium-dependent transmembrane proteins of the group of adhesion proteins. They play a rol...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549730/ https://www.ncbi.nlm.nih.gov/pubmed/23066729 http://dx.doi.org/10.1186/1472-6890-12-19 |
_version_ | 1782256456466169856 |
---|---|
author | Bremmer, Felix Hemmerlein, Bernhard Strauss, Arne Burfeind, Peter Thelen, Paul Radzun, Heinz-Joachim Behnes, Carl Ludwig |
author_facet | Bremmer, Felix Hemmerlein, Bernhard Strauss, Arne Burfeind, Peter Thelen, Paul Radzun, Heinz-Joachim Behnes, Carl Ludwig |
author_sort | Bremmer, Felix |
collection | PubMed |
description | BACKGROUND: Testicular germ cell tumours (TGCTs) are the most common malignancy in young men aged 18–35 years. They are clinically and histologically subdivided into seminomas and non-seminomas. Cadherins are calcium-dependent transmembrane proteins of the group of adhesion proteins. They play a role in the stabilization of cell-cell contacts, the embryonic morphogenesis, in the maintenance of cell polarity and signal transduction. N-cadherin (CDH2), the neuronal cadherin, stimulates cell-cell contacts during migration and invasion of cells and is able to suppress tumour cell growth. METHODS: Tumour tissues were acquired from 113 male patients and investigated by immunohistochemistry, as were the three TGCT cell lines NCCIT, NTERA-2 and Tcam2. A monoclonal antibody against N-cadherin was used. RESULTS: Tumour-free testis and intratubular germ cell neoplasias (unclassified) (IGCNU) strongly expressed N-cadherin within the cytoplasm. In all seminomas investigated, N-cadherin expression displayed a membrane-bound location. In addition, the teratomas and yolk sac tumours investigated also differentially expressed N-cadherin. In contrast, no N-cadherin could be detected in any of the embryonal carcinomas and chorionic carcinomas examined. This expression pattern was also seen in the investigated mixed tumours consisting of seminomas, teratomas, and embryonal carcinoma. CONCLUSIONS: N-cadherin expression can be used to differentiate embryonal carcinomas and chorionic carcinomas from other histological subtypes of TGCT. |
format | Online Article Text |
id | pubmed-3549730 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35497302013-01-23 N-cadherin expression in malignant germ cell tumours of the testis Bremmer, Felix Hemmerlein, Bernhard Strauss, Arne Burfeind, Peter Thelen, Paul Radzun, Heinz-Joachim Behnes, Carl Ludwig BMC Clin Pathol Research Article BACKGROUND: Testicular germ cell tumours (TGCTs) are the most common malignancy in young men aged 18–35 years. They are clinically and histologically subdivided into seminomas and non-seminomas. Cadherins are calcium-dependent transmembrane proteins of the group of adhesion proteins. They play a role in the stabilization of cell-cell contacts, the embryonic morphogenesis, in the maintenance of cell polarity and signal transduction. N-cadherin (CDH2), the neuronal cadherin, stimulates cell-cell contacts during migration and invasion of cells and is able to suppress tumour cell growth. METHODS: Tumour tissues were acquired from 113 male patients and investigated by immunohistochemistry, as were the three TGCT cell lines NCCIT, NTERA-2 and Tcam2. A monoclonal antibody against N-cadherin was used. RESULTS: Tumour-free testis and intratubular germ cell neoplasias (unclassified) (IGCNU) strongly expressed N-cadherin within the cytoplasm. In all seminomas investigated, N-cadherin expression displayed a membrane-bound location. In addition, the teratomas and yolk sac tumours investigated also differentially expressed N-cadherin. In contrast, no N-cadherin could be detected in any of the embryonal carcinomas and chorionic carcinomas examined. This expression pattern was also seen in the investigated mixed tumours consisting of seminomas, teratomas, and embryonal carcinoma. CONCLUSIONS: N-cadherin expression can be used to differentiate embryonal carcinomas and chorionic carcinomas from other histological subtypes of TGCT. BioMed Central 2012-10-15 /pmc/articles/PMC3549730/ /pubmed/23066729 http://dx.doi.org/10.1186/1472-6890-12-19 Text en Copyright ©2012 Bremmer et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Bremmer, Felix Hemmerlein, Bernhard Strauss, Arne Burfeind, Peter Thelen, Paul Radzun, Heinz-Joachim Behnes, Carl Ludwig N-cadherin expression in malignant germ cell tumours of the testis |
title | N-cadherin expression in malignant germ cell tumours of the testis |
title_full | N-cadherin expression in malignant germ cell tumours of the testis |
title_fullStr | N-cadherin expression in malignant germ cell tumours of the testis |
title_full_unstemmed | N-cadherin expression in malignant germ cell tumours of the testis |
title_short | N-cadherin expression in malignant germ cell tumours of the testis |
title_sort | n-cadherin expression in malignant germ cell tumours of the testis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549730/ https://www.ncbi.nlm.nih.gov/pubmed/23066729 http://dx.doi.org/10.1186/1472-6890-12-19 |
work_keys_str_mv | AT bremmerfelix ncadherinexpressioninmalignantgermcelltumoursofthetestis AT hemmerleinbernhard ncadherinexpressioninmalignantgermcelltumoursofthetestis AT straussarne ncadherinexpressioninmalignantgermcelltumoursofthetestis AT burfeindpeter ncadherinexpressioninmalignantgermcelltumoursofthetestis AT thelenpaul ncadherinexpressioninmalignantgermcelltumoursofthetestis AT radzunheinzjoachim ncadherinexpressioninmalignantgermcelltumoursofthetestis AT behnescarlludwig ncadherinexpressioninmalignantgermcelltumoursofthetestis |